Latest papers

The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients -- A modified Delphi study

Drug-drug interaction studies in preclinical species: should metabolite(s) kinetics be studied?

A short note on the discipline of Clinical Pharmacology.

Conference scene: initiatives on future biobanking in pharmacogenomics.

Biosimilars / Follow-on proteins - a case for clinical pharmacology.

Professor Paul M. Vanhoutte--portrait of an extraordinary medical researcher. Interview by Iona MacDonald MA.

Abstracts of the ESCP 37th European Symposium on Clinical Pharmacy, Pharmaceutical Care Models, and Therapeutic Innovations. Dubrovnik, Croatia. October 21-24, 2008.

Abstracts of the 50th Annual Meeting of the Deutsche Gesellschaft für Experimentelle und Klinische Pharmakologie und Toxikologie. Mainz, Germany. March 10-12, 2009.

[Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].

Update of FDA's Critical Path Initiative.

[Pharmacists congratulate clinical pharmacologists]

Joint meeting of the LXXIInd annual meeting of the Hungarian physiological society and the Hungarian society for experimental and clinical pharmacology (June 4–6, 2008, Debrecen, Hungary)

The effects of problem-based learning integration in a course on rational drug use: a comparative study between two Croatian medical schools.

Resurrecting clinical pharmacology as a context for Alzheimer disease drug development.

Discontinued drugs 2007: central and peripheral nervous system drugs.

Challenges in pediatric drug development: a pharmaceutical industry perspective.

[Good care requires several information services].

Establishing an international collaborative network in pediatric pharmacology. Proceedings of the Toronto Satellite in Pediatric Pharmacology, a satellite meeting of the IXth World Conference on Clinical Pharmacology and Therapeutics. July 25-26, 2008. Toronto, Ontario, Canada.

Lithium: Updated Human Knowledge Using an Evidence-Based Approach

Topical microbicides to prevent HIV: clinical drug development challenges.